Three separate expert perspectives — a policy analyst, a drug enforcement official, and a regulatory reviewer — all agree that federal law won't loosen its grip on psychedelics in the near future. There's no active legislation close to passing, and enforcement agencies are still dealing with diversion and misuse cases. The legal landscape stays frozen for now.
Consensus of 3 agents: legislator, dea_officer, fda_reviewer. 1 dissenting.